Structure‐Based Design of Platinum(II) Complexes as c‐<i>myc</i> Oncogene Down‐Regulators and Luminescent Probes for G‐Quadruplex DNA

Chemistry - A European Journal - Tập 16 Số 23 - Trang 6900-6911 - 2010
Ping Wang1, Chung‐Hang Leung1, Dik‐Lung Ma2,1, Siu‐Cheong Yan1, Chi‐Ming Che1
1Department of Chemistry and Open Laboratory of Chemical Biology of the Institute of Molecular Technology for Drug Discovery and Synthesis, The University of Hong Kong, Pokfulam Road, Hong Kong (P.R. China),
2Current address: Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong (P.R. China)

Tóm tắt

AbstractA series of platinum(II) complexes with tridentate ligands was synthesized and their interactions with G‐quadruplex DNA within the c‐myc gene promoter were evaluated. Complex 1, which has a flat planar 2,6‐bis(benzimidazol‐2‐yl)pyridine (bzimpy) scaffold, was found to stabilize the c‐myc G‐quadruplex structure in a cell‐free system. An in silico G‐quadruplex DNA model has been constructed for structure‐based virtual screening to develop new PtII‐based complexes with superior inhibitory activities. By using complex 1 as the initial structure for hit‐to‐lead optimization, bzimpy and related 2,6‐bis(pyrazol‐3‐yl)pyridine (dPzPy) scaffolds containing amine side‐chains emerge as the top candidates. Six of the top‐scoring complexes were synthesized and their interactions with c‐myc G‐quadruplex DNA have been investigated. The results revealed that all of the complexes have the ability to stabilize the c‐myc G‐quadruplex. Complex 3 a ([PtIIL2R]+; L2=2,6‐bis[1‐(3‐piperidinepropyl)‐1H‐enzo[d]imidazol‐2‐yl]pyridine, R=Cl) displayed the strongest inhibition in a cell‐free system (IC50=2.2 μM) and was 3.3‐fold more potent than that of 1. Complexes 3 a and 4 a ([PtIIL3R]+; L3=2,6‐bis[1‐(3‐morpholinopropyl)‐1H‐pyrazol‐3‐yl]pyridine, R=Cl) were found to effectively inhibit c‐myc gene expression in human hepatocarcinoma cells with IC50 values of ≈17 μM, whereas initial hit 1 displayed no significant effect on gene expression at concentrations up to 50 μM. Complexes 3 a and 4 a have a strong preference for G‐quadruplex DNA over duplex DNA, as revealed by competition dialysis experiments and absorption titration; 3 a and 4 a bind G‐quadruplex DNA with binding constants (K) of approximately 106–107 dm3 mol−1, which are at least an order of magnitude higher than the K values for duplex DNA. NMR spectroscopic titration experiments and molecular modeling showed that 4 a binds c‐myc G‐quadruplex DNA through an external end‐stacking mode at the 3′‐terminal face of the G‐quadruplex. Intriguingly, binding of c‐myc G‐quadruplex DNA by 3 b is accompanied by an increase of up to 38‐fold in photoluminescence intensity at λmax=622 nm.

Từ khóa


Tài liệu tham khảo

10.1038/nrc749

10.1016/S0163-7258(99)00020-0

10.2174/0929867303666220307172622

10.1002/ange.200300589

10.1002/anie.200300589

10.1016/S0065-230X(08)60476-5

10.1146/annurev.bi.61.070192.004113

10.1096/fasebj.12.9.633

 

10.1016/S0959-437X(99)00046-5

10.1093/nar/gkm711

 

10.1074/jbc.270.16.9494

10.1073/pnas.93.12.5830

10.1093/nar/26.5.1167

10.1006/bbrc.2000.3783

 

10.1023/A:1005541114029

10.1021/bi048242p

10.1021/jm970199z

10.1016/j.bbrc.2004.08.150

Grand C. L., 2002, Mol. Cancer Ther., 1, 565

10.1021/ja0444482

10.1074/jbc.M005962200

 

10.1021/jm0610088

10.1021/jm800497p

10.1016/j.bmc.2008.07.029

10.1021/ja973792e

10.1016/S0960-894X(99)00394-7

 

10.1021/bi001565a

10.1021/bi011363u

10.1021/bi020310p

10.1021/bi0483209

10.1039/b211634k

10.1002/cbic.200400113

10.1021/ja065591t

10.1039/b708635k

10.1007/s00775-007-0273-3

10.1007/s00775-007-0292-0

10.1021/ic8016547

10.1021/ic7021209

10.1002/chem.200700783

 

10.1021/ja058509n

10.1039/b820086f

 

10.1021/ja806045x

10.1002/chem.200901943

10.1002/ange.200903685

10.1002/anie.200903685

 

10.1002/(SICI)1521-3765(19991105)5:11<3350::AID-CHEM3350>3.0.CO;2-J

10.1002/cbic.200390015

10.1002/chem.200304964

10.1039/b507114c

 

10.1021/ja00062a007

10.1016/0076-6879(93)26027-7

10.1039/cc9960001039

10.1021/cr9804341

10.1021/ic9901315

10.1039/b710949k

10.1016/j.jinorgbio.2007.07.002

10.1016/j.jinorgbio.2009.08.002

10.1002/ange.200705319

10.1002/anie.200705319

10.1038/nature755

10.1016/j.poly.2005.07.021

 

10.1055/s-2001-9761

10.1016/S0020-1693(02)00754-5

 

10.1021/ic025580a

10.1021/om049898h

10.1002/ejic.200500335

10.1002/chem.200701914

10.1021/ja040022b

10.1021/ja048805k

 

10.1002/(SICI)1097-0134(1997)1 <215::AID-PROT29>3.0.CO;2-Q

10.1002/cmdc.200700342

10.1021/ja984153m

10.1021/ja00072a004

10.1038/nchembio723

10.1016/S0022-2836(02)01354-2

10.1021/bi001584k

10.1016/S0014-5793(98)01043-6

10.1016/j.tet.2007.10.045

10.1016/j.ymeth.2007.08.003

 

10.1063/1.448799

10.1063/1.448800

10.1063/1.448975